GNE-3511
| CAS No. | 1496581-76-0 | Cat. No. | BCP19925 |
| Name | GNE-3511 | ||
| Synonyms | GNE3511;GNE 3511; | ||
| Formula | C23H26F2N6O | M. Wt | 440.49 |
| Description | GNE-3511 is a potent and selective dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models. GNE-3511 displays concentration-dependent protection of neurons from degeneration in vitro and demonstrated dose-dependent activity in two different animal models of disease. GNE-3511 displays protection of primary neurons in an in vitro axon degeneration assay as well as activity in the mouse models of glaucoma/optic neuropathy (optic nerve crush) and Parkinson’s disease (MPTP) after oral dosing. | ||
| Pathways | MAPK Pathway | ||
| Targets | MAP3K | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.